Zevra Therapeutics, Inc. ZVRA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s total liabilities?
- Zevra Therapeutics, Inc. (ZVRA) reported total liabilities of $8.16M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s total liabilities changed year-over-year?
- Zevra Therapeutics, Inc.'s total liabilities decreased by 93.8% year-over-year, from $131.69M to $8.16M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s total liabilities has grown at a -32.2% compound annual growth rate (CAGR), from $77.62M to $11.12M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.